Global Drug-Eluting Bioabsorbable Stents Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Drug-Eluting Bioabsorbable Stents Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Drug-Eluting Bioabsorbable Stents by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Drug-Eluting Bioabsorbable Stents by Country/Region, 2017, 2022 & 2028

2.2 Drug-Eluting Bioabsorbable Stents Segment by Type

2.2.1 Serolimus and Paclitaxel Drug-Eluting Stents

2.2.2 Sirolimus Drug Eluting Stents

2.3 Drug-Eluting Bioabsorbable Stents Sales by Type

2.3.1 Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Type (2017-2022)

2.3.2 Global Drug-Eluting Bioabsorbable Stents Revenue and Market Share by Type (2017-2022)

2.3.3 Global Drug-Eluting Bioabsorbable Stents Sale Price by Type (2017-2022)

2.4 Drug-Eluting Bioabsorbable Stents Segment by Application

2.4.1 Coronary Artery Diseases

2.4.2 Peripheral Artery Diseases

2.5 Drug-Eluting Bioabsorbable Stents Sales by Application

2.5.1 Global Drug-Eluting Bioabsorbable Stents Sale Market Share by Application (2017-2022)

2.5.2 Global Drug-Eluting Bioabsorbable Stents Revenue and Market Share by Application (2017-2022)

2.5.3 Global Drug-Eluting Bioabsorbable Stents Sale Price by Application (2017-2022)

3 Global Drug-Eluting Bioabsorbable Stents by Company

3.1 Global Drug-Eluting Bioabsorbable Stents Breakdown Data by Company

3.1.1 Global Drug-Eluting Bioabsorbable Stents Annual Sales by Company (2020-2022)

3.1.2 Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Company (2020-2022)

3.2 Global Drug-Eluting Bioabsorbable Stents Annual Revenue by Company (2020-2022)

3.2.1 Global Drug-Eluting Bioabsorbable Stents Revenue by Company (2020-2022)

3.2.2 Global Drug-Eluting Bioabsorbable Stents Revenue Market Share by Company (2020-2022)

3.3 Global Drug-Eluting Bioabsorbable Stents Sale Price by Company

3.4 Key Manufacturers Drug-Eluting Bioabsorbable Stents Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Drug-Eluting Bioabsorbable Stents Product Location Distribution

3.4.2 Players Drug-Eluting Bioabsorbable Stents Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Drug-Eluting Bioabsorbable Stents by Geographic Region

4.1 World Historic Drug-Eluting Bioabsorbable Stents Market Size by Geographic Region (2017-2022)

4.1.1 Global Drug-Eluting Bioabsorbable Stents Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Drug-Eluting Bioabsorbable Stents Annual Revenue by Geographic Region

4.2 World Historic Drug-Eluting Bioabsorbable Stents Market Size by Country/Region (2017-2022)

4.2.1 Global Drug-Eluting Bioabsorbable Stents Annual Sales by Country/Region (2017-2022)

4.2.2 Global Drug-Eluting Bioabsorbable Stents Annual Revenue by Country/Region

4.3 Americas Drug-Eluting Bioabsorbable Stents Sales Growth

4.4 APAC Drug-Eluting Bioabsorbable Stents Sales Growth

4.5 Europe Drug-Eluting Bioabsorbable Stents Sales Growth

4.6 Middle East & Africa Drug-Eluting Bioabsorbable Stents Sales Growth

5 Americas

5.1 Americas Drug-Eluting Bioabsorbable Stents Sales by Country

5.1.1 Americas Drug-Eluting Bioabsorbable Stents Sales by Country (2017-2022)

5.1.2 Americas Drug-Eluting Bioabsorbable Stents Revenue by Country (2017-2022)

5.2 Americas Drug-Eluting Bioabsorbable Stents Sales by Type

5.3 Americas Drug-Eluting Bioabsorbable Stents Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Drug-Eluting Bioabsorbable Stents Sales by Region

6.1.1 APAC Drug-Eluting Bioabsorbable Stents Sales by Region (2017-2022)

6.1.2 APAC Drug-Eluting Bioabsorbable Stents Revenue by Region (2017-2022)

6.2 APAC Drug-Eluting Bioabsorbable Stents Sales by Type

6.3 APAC Drug-Eluting Bioabsorbable Stents Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Drug-Eluting Bioabsorbable Stents by Country

7.1.1 Europe Drug-Eluting Bioabsorbable Stents Sales by Country (2017-2022)

7.1.2 Europe Drug-Eluting Bioabsorbable Stents Revenue by Country (2017-2022)

7.2 Europe Drug-Eluting Bioabsorbable Stents Sales by Type

7.3 Europe Drug-Eluting Bioabsorbable Stents Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Drug-Eluting Bioabsorbable Stents by Country

8.1.1 Middle East & Africa Drug-Eluting Bioabsorbable Stents Sales by Country (2017-2022)

8.1.2 Middle East & Africa Drug-Eluting Bioabsorbable Stents Revenue by Country (2017-2022)

8.2 Middle East & Africa Drug-Eluting Bioabsorbable Stents Sales by Type

8.3 Middle East & Africa Drug-Eluting Bioabsorbable Stents Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Drug-Eluting Bioabsorbable Stents

10.3 Manufacturing Process Analysis of Drug-Eluting Bioabsorbable Stents

10.4 Industry Chain Structure of Drug-Eluting Bioabsorbable Stents

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Drug-Eluting Bioabsorbable Stents Distributors

11.3 Drug-Eluting Bioabsorbable Stents Customer

12 World Forecast Review for Drug-Eluting Bioabsorbable Stents by Geographic Region

12.1 Global Drug-Eluting Bioabsorbable Stents Market Size Forecast by Region

12.1.1 Global Drug-Eluting Bioabsorbable Stents Forecast by Region (2023-2028)

12.1.2 Global Drug-Eluting Bioabsorbable Stents Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Drug-Eluting Bioabsorbable Stents Forecast by Type

12.7 Global Drug-Eluting Bioabsorbable Stents Forecast by Application

13 Key Players Analysis

13.1 Medtronic

13.1.1 Medtronic Company Information

13.1.2 Medtronic Drug-Eluting Bioabsorbable Stents Product Offered

13.1.3 Medtronic Drug-Eluting Bioabsorbable Stents Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Medtronic Main Business Overview

13.1.5 Medtronic Latest Developments

13.2 B.Braun Melsungen

13.2.1 B.Braun Melsungen Company Information

13.2.2 B.Braun Melsungen Drug-Eluting Bioabsorbable Stents Product Offered

13.2.3 B.Braun Melsungen Drug-Eluting Bioabsorbable Stents Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 B.Braun Melsungen Main Business Overview

13.2.5 B.Braun Melsungen Latest Developments

13.3 Abbott Laboratories

13.3.1 Abbott Laboratories Company Information

13.3.2 Abbott Laboratories Drug-Eluting Bioabsorbable Stents Product Offered

13.3.3 Abbott Laboratories Drug-Eluting Bioabsorbable Stents Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Abbott Laboratories Main Business Overview

13.3.5 Abbott Laboratories Latest Developments

13.4 Boston Scientific Corporation

13.4.1 Boston Scientific Corporation Company Information

13.4.2 Boston Scientific Corporation Drug-Eluting Bioabsorbable Stents Product Offered

13.4.3 Boston Scientific Corporation Drug-Eluting Bioabsorbable Stents Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Boston Scientific Corporation Main Business Overview

13.4.5 Boston Scientific Corporation Latest Developments

13.5 Biosensors International

13.5.1 Biosensors International Company Information

13.5.2 Biosensors International Drug-Eluting Bioabsorbable Stents Product Offered

13.5.3 Biosensors International Drug-Eluting Bioabsorbable Stents Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Biosensors International Main Business Overview

13.5.5 Biosensors International Latest Developments

13.6 Terumo Corporation.

13.6.1 Terumo Corporation. Company Information

13.6.2 Terumo Corporation. Drug-Eluting Bioabsorbable Stents Product Offered

13.6.3 Terumo Corporation. Drug-Eluting Bioabsorbable Stents Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Terumo Corporation. Main Business Overview

13.6.5 Terumo Corporation. Latest Developments

13.7 MicroPort Scientific Corporation

13.7.1 MicroPort Scientific Corporation Company Information

13.7.2 MicroPort Scientific Corporation Drug-Eluting Bioabsorbable Stents Product Offered

13.7.3 MicroPort Scientific Corporation Drug-Eluting Bioabsorbable Stents Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 MicroPort Scientific Corporation Main Business Overview

13.7.5 MicroPort Scientific Corporation Latest Developments

13.8 Alvimedica

13.8.1 Alvimedica Company Information

13.8.2 Alvimedica Drug-Eluting Bioabsorbable Stents Product Offered

13.8.3 Alvimedica Drug-Eluting Bioabsorbable Stents Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Alvimedica Main Business Overview

13.8.5 Alvimedica Latest Developments

13.9 Biotronik

13.9.1 Biotronik Company Information

13.9.2 Biotronik Drug-Eluting Bioabsorbable Stents Product Offered

13.9.3 Biotronik Drug-Eluting Bioabsorbable Stents Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Biotronik Main Business Overview

13.9.5 Biotronik Latest Developments

13.10 Elixir Medical Corporation

13.10.1 Elixir Medical Corporation Company Information

13.10.2 Elixir Medical Corporation Drug-Eluting Bioabsorbable Stents Product Offered

13.10.3 Elixir Medical Corporation Drug-Eluting Bioabsorbable Stents Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Elixir Medical Corporation Main Business Overview

13.10.5 Elixir Medical Corporation Latest Developments

13.11 Innovative Health Technologies

13.11.1 Innovative Health Technologies Company Information

13.11.2 Innovative Health Technologies Drug-Eluting Bioabsorbable Stents Product Offered

13.11.3 Innovative Health Technologies Drug-Eluting Bioabsorbable Stents Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Innovative Health Technologies Main Business Overview

13.11.5 Innovative Health Technologies Latest Developments

14 Research Findings and Conclusion

Table 1. Drug-Eluting Bioabsorbable Stents Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Drug-Eluting Bioabsorbable Stents Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Serolimus and Paclitaxel Drug-Eluting Stents

Table 4. Major Players of Sirolimus Drug Eluting Stents

Table 5. Global Drug-Eluting Bioabsorbable Stents Sales by Type (2017-2022) & (K Units)

Table 6. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Type (2017-2022)

Table 7. Global Drug-Eluting Bioabsorbable Stents Revenue by Type (2017-2022) & ($ million)

Table 8. Global Drug-Eluting Bioabsorbable Stents Revenue Market Share by Type (2017-2022)

Table 9. Global Drug-Eluting Bioabsorbable Stents Sale Price by Type (2017-2022) & (USD/Unit)

Table 10. Global Drug-Eluting Bioabsorbable Stents Sales by Application (2017-2022) & (K Units)

Table 11. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Application (2017-2022)

Table 12. Global Drug-Eluting Bioabsorbable Stents Revenue by Application (2017-2022)

Table 13. Global Drug-Eluting Bioabsorbable Stents Revenue Market Share by Application (2017-2022)

Table 14. Global Drug-Eluting Bioabsorbable Stents Sale Price by Application (2017-2022) & (USD/Unit)

Table 15. Global Drug-Eluting Bioabsorbable Stents Sales by Company (2020-2022) & (K Units)

Table 16. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Company (2020-2022)

Table 17. Global Drug-Eluting Bioabsorbable Stents Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Drug-Eluting Bioabsorbable Stents Revenue Market Share by Company (2020-2022)

Table 19. Global Drug-Eluting Bioabsorbable Stents Sale Price by Company (2020-2022) & (USD/Unit)

Table 20. Key Manufacturers Drug-Eluting Bioabsorbable Stents Producing Area Distribution and Sales Area

Table 21. Players Drug-Eluting Bioabsorbable Stents Products Offered

Table 22. Drug-Eluting Bioabsorbable Stents Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Drug-Eluting Bioabsorbable Stents Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Drug-Eluting Bioabsorbable Stents Sales Market Share Geographic Region (2017-2022)

Table 27. Global Drug-Eluting Bioabsorbable Stents Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Drug-Eluting Bioabsorbable Stents Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Drug-Eluting Bioabsorbable Stents Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Country/Region (2017-2022)

Table 31. Global Drug-Eluting Bioabsorbable Stents Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Drug-Eluting Bioabsorbable Stents Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Drug-Eluting Bioabsorbable Stents Sales by Country (2017-2022) & (K Units)

Table 34. Americas Drug-Eluting Bioabsorbable Stents Sales Market Share by Country (2017-2022)

Table 35. Americas Drug-Eluting Bioabsorbable Stents Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Drug-Eluting Bioabsorbable Stents Revenue Market Share by Country (2017-2022)

Table 37. Americas Drug-Eluting Bioabsorbable Stents Sales by Type (2017-2022) & (K Units)

Table 38. Americas Drug-Eluting Bioabsorbable Stents Sales Market Share by Type (2017-2022)

Table 39. Americas Drug-Eluting Bioabsorbable Stents Sales by Application (2017-2022) & (K Units)

Table 40. Americas Drug-Eluting Bioabsorbable Stents Sales Market Share by Application (2017-2022)

Table 41. APAC Drug-Eluting Bioabsorbable Stents Sales by Region (2017-2022) & (K Units)

Table 42. APAC Drug-Eluting Bioabsorbable Stents Sales Market Share by Region (2017-2022)

Table 43. APAC Drug-Eluting Bioabsorbable Stents Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Drug-Eluting Bioabsorbable Stents Revenue Market Share by Region (2017-2022)

Table 45. APAC Drug-Eluting Bioabsorbable Stents Sales by Type (2017-2022) & (K Units)

Table 46. APAC Drug-Eluting Bioabsorbable Stents Sales Market Share by Type (2017-2022)

Table 47. APAC Drug-Eluting Bioabsorbable Stents Sales by Application (2017-2022) & (K Units)

Table 48. APAC Drug-Eluting Bioabsorbable Stents Sales Market Share by Application (2017-2022)

Table 49. Europe Drug-Eluting Bioabsorbable Stents Sales by Country (2017-2022) & (K Units)

Table 50. Europe Drug-Eluting Bioabsorbable Stents Sales Market Share by Country (2017-2022)

Table 51. Europe Drug-Eluting Bioabsorbable Stents Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Drug-Eluting Bioabsorbable Stents Revenue Market Share by Country (2017-2022)

Table 53. Europe Drug-Eluting Bioabsorbable Stents Sales by Type (2017-2022) & (K Units)

Table 54. Europe Drug-Eluting Bioabsorbable Stents Sales Market Share by Type (2017-2022)

Table 55. Europe Drug-Eluting Bioabsorbable Stents Sales by Application (2017-2022) & (K Units)

Table 56. Europe Drug-Eluting Bioabsorbable Stents Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Drug-Eluting Bioabsorbable Stents Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Drug-Eluting Bioabsorbable Stents Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Drug-Eluting Bioabsorbable Stents Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Drug-Eluting Bioabsorbable Stents Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Drug-Eluting Bioabsorbable Stents Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Drug-Eluting Bioabsorbable Stents Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Drug-Eluting Bioabsorbable Stents Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Drug-Eluting Bioabsorbable Stents Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Drug-Eluting Bioabsorbable Stents

Table 66. Key Market Challenges & Risks of Drug-Eluting Bioabsorbable Stents

Table 67. Key Industry Trends of Drug-Eluting Bioabsorbable Stents

Table 68. Drug-Eluting Bioabsorbable Stents Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Drug-Eluting Bioabsorbable Stents Distributors List

Table 71. Drug-Eluting Bioabsorbable Stents Customer List

Table 72. Global Drug-Eluting Bioabsorbable Stents Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Drug-Eluting Bioabsorbable Stents Sales Market Forecast by Region

Table 74. Global Drug-Eluting Bioabsorbable Stents Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Drug-Eluting Bioabsorbable Stents Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Drug-Eluting Bioabsorbable Stents Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Drug-Eluting Bioabsorbable Stents Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Drug-Eluting Bioabsorbable Stents Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Drug-Eluting Bioabsorbable Stents Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Drug-Eluting Bioabsorbable Stents Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Drug-Eluting Bioabsorbable Stents Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Drug-Eluting Bioabsorbable Stents Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Drug-Eluting Bioabsorbable Stents Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Drug-Eluting Bioabsorbable Stents Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Drug-Eluting Bioabsorbable Stents Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Drug-Eluting Bioabsorbable Stents Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Drug-Eluting Bioabsorbable Stents Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Drug-Eluting Bioabsorbable Stents Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Drug-Eluting Bioabsorbable Stents Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Drug-Eluting Bioabsorbable Stents Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Drug-Eluting Bioabsorbable Stents Revenue Market Share Forecast by Application (2023-2028)

Table 92. Medtronic Basic Information, Drug-Eluting Bioabsorbable Stents Manufacturing Base, Sales Area and Its Competitors

Table 93. Medtronic Drug-Eluting Bioabsorbable Stents Product Offered

Table 94. Medtronic Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 95. Medtronic Main Business

Table 96. Medtronic Latest Developments

Table 97. B.Braun Melsungen Basic Information, Drug-Eluting Bioabsorbable Stents Manufacturing Base, Sales Area and Its Competitors

Table 98. B.Braun Melsungen Drug-Eluting Bioabsorbable Stents Product Offered

Table 99. B.Braun Melsungen Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 100. B.Braun Melsungen Main Business

Table 101. B.Braun Melsungen Latest Developments

Table 102. Abbott Laboratories Basic Information, Drug-Eluting Bioabsorbable Stents Manufacturing Base, Sales Area and Its Competitors

Table 103. Abbott Laboratories Drug-Eluting Bioabsorbable Stents Product Offered

Table 104. Abbott Laboratories Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 105. Abbott Laboratories Main Business

Table 106. Abbott Laboratories Latest Developments

Table 107. Boston Scientific Corporation Basic Information, Drug-Eluting Bioabsorbable Stents Manufacturing Base, Sales Area and Its Competitors

Table 108. Boston Scientific Corporation Drug-Eluting Bioabsorbable Stents Product Offered

Table 109. Boston Scientific Corporation Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 110. Boston Scientific Corporation Main Business

Table 111. Boston Scientific Corporation Latest Developments

Table 112. Biosensors International Basic Information, Drug-Eluting Bioabsorbable Stents Manufacturing Base, Sales Area and Its Competitors

Table 113. Biosensors International Drug-Eluting Bioabsorbable Stents Product Offered

Table 114. Biosensors International Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 115. Biosensors International Main Business

Table 116. Biosensors International Latest Developments

Table 117. Terumo Corporation. Basic Information, Drug-Eluting Bioabsorbable Stents Manufacturing Base, Sales Area and Its Competitors

Table 118. Terumo Corporation. Drug-Eluting Bioabsorbable Stents Product Offered

Table 119. Terumo Corporation. Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 120. Terumo Corporation. Main Business

Table 121. Terumo Corporation. Latest Developments

Table 122. MicroPort Scientific Corporation Basic Information, Drug-Eluting Bioabsorbable Stents Manufacturing Base, Sales Area and Its Competitors

Table 123. MicroPort Scientific Corporation Drug-Eluting Bioabsorbable Stents Product Offered

Table 124. MicroPort Scientific Corporation Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 125. MicroPort Scientific Corporation Main Business

Table 126. MicroPort Scientific Corporation Latest Developments

Table 127. Alvimedica Basic Information, Drug-Eluting Bioabsorbable Stents Manufacturing Base, Sales Area and Its Competitors

Table 128. Alvimedica Drug-Eluting Bioabsorbable Stents Product Offered

Table 129. Alvimedica Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 130. Alvimedica Main Business

Table 131. Alvimedica Latest Developments

Table 132. Biotronik Basic Information, Drug-Eluting Bioabsorbable Stents Manufacturing Base, Sales Area and Its Competitors

Table 133. Biotronik Drug-Eluting Bioabsorbable Stents Product Offered

Table 134. Biotronik Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 135. Biotronik Main Business

Table 136. Biotronik Latest Developments

Table 137. Elixir Medical Corporation Basic Information, Drug-Eluting Bioabsorbable Stents Manufacturing Base, Sales Area and Its Competitors

Table 138. Elixir Medical Corporation Drug-Eluting Bioabsorbable Stents Product Offered

Table 139. Elixir Medical Corporation Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 140. Elixir Medical Corporation Main Business

Table 141. Elixir Medical Corporation Latest Developments

Table 142. Innovative Health Technologies Basic Information, Drug-Eluting Bioabsorbable Stents Manufacturing Base, Sales Area and Its Competitors

Table 143. Innovative Health Technologies Drug-Eluting Bioabsorbable Stents Product Offered

Table 144. Innovative Health Technologies Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 145. Innovative Health Technologies Main Business

Table 146. Innovative Health Technologies Latest Developments

List of Figures

Figure 1. Picture of Drug-Eluting Bioabsorbable Stents

Figure 2. Drug-Eluting Bioabsorbable Stents Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Drug-Eluting Bioabsorbable Stents Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Drug-Eluting Bioabsorbable Stents Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Drug-Eluting Bioabsorbable Stents Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Serolimus and Paclitaxel Drug-Eluting Stents

Figure 10. Product Picture of Sirolimus Drug Eluting Stents

Figure 11. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Type in 2021

Figure 12. Global Drug-Eluting Bioabsorbable Stents Revenue Market Share by Type (2017-2022)

Figure 13. Drug-Eluting Bioabsorbable Stents Consumed in Coronary Artery Diseases

Figure 14. Global Drug-Eluting Bioabsorbable Stents Market: Coronary Artery Diseases (2017-2022) & (K Units)

Figure 15. Drug-Eluting Bioabsorbable Stents Consumed in Peripheral Artery Diseases

Figure 16. Global Drug-Eluting Bioabsorbable Stents Market: Peripheral Artery Diseases (2017-2022) & (K Units)

Figure 17. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Application (2017-2022)

Figure 18. Global Drug-Eluting Bioabsorbable Stents Revenue Market Share by Application in 2021

Figure 19. Drug-Eluting Bioabsorbable Stents Revenue Market by Company in 2021 ($ Million)

Figure 20. Global Drug-Eluting Bioabsorbable Stents Revenue Market Share by Company in 2021

Figure 21. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Geographic Region (2017-2022)

Figure 22. Global Drug-Eluting Bioabsorbable Stents Revenue Market Share by Geographic Region in 2021

Figure 23. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Region (2017-2022)

Figure 24. Global Drug-Eluting Bioabsorbable Stents Revenue Market Share by Country/Region in 2021

Figure 25. Americas Drug-Eluting Bioabsorbable Stents Sales 2017-2022 (K Units)

Figure 26. Americas Drug-Eluting Bioabsorbable Stents Revenue 2017-2022 ($ Millions)

Figure 27. APAC Drug-Eluting Bioabsorbable Stents Sales 2017-2022 (K Units)

Figure 28. APAC Drug-Eluting Bioabsorbable Stents Revenue 2017-2022 ($ Millions)

Figure 29. Europe Drug-Eluting Bioabsorbable Stents Sales 2017-2022 (K Units)

Figure 30. Europe Drug-Eluting Bioabsorbable Stents Revenue 2017-2022 ($ Millions)

Figure 31. Middle East & Africa Drug-Eluting Bioabsorbable Stents Sales 2017-2022 (K Units)

Figure 32. Middle East & Africa Drug-Eluting Bioabsorbable Stents Revenue 2017-2022 ($ Millions)

Figure 33. Americas Drug-Eluting Bioabsorbable Stents Sales Market Share by Country in 2021

Figure 34. Americas Drug-Eluting Bioabsorbable Stents Revenue Market Share by Country in 2021

Figure 35. United States Drug-Eluting Bioabsorbable Stents Revenue Growth 2017-2022 ($ Millions)

Figure 36. Canada Drug-Eluting Bioabsorbable Stents Revenue Growth 2017-2022 ($ Millions)

Figure 37. Mexico Drug-Eluting Bioabsorbable Stents Revenue Growth 2017-2022 ($ Millions)

Figure 38. Brazil Drug-Eluting Bioabsorbable Stents Revenue Growth 2017-2022 ($ Millions)

Figure 39. APAC Drug-Eluting Bioabsorbable Stents Sales Market Share by Region in 2021

Figure 40. APAC Drug-Eluting Bioabsorbable Stents Revenue Market Share by Regions in 2021

Figure 41. China Drug-Eluting Bioabsorbable Stents Revenue Growth 2017-2022 ($ Millions)

Figure 42. Japan Drug-Eluting Bioabsorbable Stents Revenue Growth 2017-2022 ($ Millions)

Figure 43. South Korea Drug-Eluting Bioabsorbable Stents Revenue Growth 2017-2022 ($ Millions)

Figure 44. Southeast Asia Drug-Eluting Bioabsorbable Stents Revenue Growth 2017-2022 ($ Millions)

Figure 45. India Drug-Eluting Bioabsorbable Stents Revenue Growth 2017-2022 ($ Millions)

Figure 46. Australia Drug-Eluting Bioabsorbable Stents Revenue Growth 2017-2022 ($ Millions)

Figure 47. Europe Drug-Eluting Bioabsorbable Stents Sales Market Share by Country in 2021

Figure 48. Europe Drug-Eluting Bioabsorbable Stents Revenue Market Share by Country in 2021

Figure 49. Germany Drug-Eluting Bioabsorbable Stents Revenue Growth 2017-2022 ($ Millions)

Figure 50. France Drug-Eluting Bioabsorbable Stents Revenue Growth 2017-2022 ($ Millions)

Figure 51. UK Drug-Eluting Bioabsorbable Stents Revenue Growth 2017-2022 ($ Millions)

Figure 52. Italy Drug-Eluting Bioabsorbable Stents Revenue Growth 2017-2022 ($ Millions)

Figure 53. Russia Drug-Eluting Bioabsorbable Stents Revenue Growth 2017-2022 ($ Millions)

Figure 54. Middle East & Africa Drug-Eluting Bioabsorbable Stents Sales Market Share by Country in 2021

Figure 55. Middle East & Africa Drug-Eluting Bioabsorbable Stents Revenue Market Share by Country in 2021

Figure 56. Egypt Drug-Eluting Bioabsorbable Stents Revenue Growth 2017-2022 ($ Millions)

Figure 57. South Africa Drug-Eluting Bioabsorbable Stents Revenue Growth 2017-2022 ($ Millions)

Figure 58. Israel Drug-Eluting Bioabsorbable Stents Revenue Growth 2017-2022 ($ Millions)

Figure 59. Turkey Drug-Eluting Bioabsorbable Stents Revenue Growth 2017-2022 ($ Millions)

Figure 60. GCC Country Drug-Eluting Bioabsorbable Stents Revenue Growth 2017-2022 ($ Millions)

Figure 61. Manufacturing Cost Structure Analysis of Drug-Eluting Bioabsorbable Stents in 2021

Figure 62. Manufacturing Process Analysis of Drug-Eluting Bioabsorbable Stents

Figure 63. Industry Chain Structure of Drug-Eluting Bioabsorbable Stents

Figure 64. Channels of Distribution

Figure 65. Distributors Profiles